The Radiation Epidemiology Branch (REB), Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute (NCI), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), is recruiting a tenure-track investigator to develop an independent research program focused on the risk of new malignancies developing in cancer survivors.
REB conducts a broad-based research program with a three-fold research mission: to characterize and quantify the carcinogenic effects of radiation; to improve our understanding of molecular mechanisms of radiation carcinogenesis; and to address issues of public concern about radiation exposure. One focus of the program is quantifying risks among cancer survivors for developing new malignancies, with particular emphasis on cancer risks following therapeutic medical radiation exposures. Investigations conducted by REB include both pediatric and adult cancer survivors and involve interdisciplinary approaches to assessing subsequent malignancy risk. Particular areas of interest include quantification of the magnitude and shape of the radiation dose-response relation following specific types of radiotherapy exposures and investigation of potential modifiers of radiation-related risks, including systemic therapies, genetic susceptibility, other patient-related factors, and other cancer risk factors. REB studies are a major source of data used to assess risks and benefits of current cancer treatment approaches and to guide the development of long-term clinical follow-up guidelines for cancer survivors. More information can be found at https://dceg.cancer.gov/about/organization/programs-ebp/reb.
Applicants must have a doctorate or equivalent qualification in epidemiology, medicine, genetics, or related field; relevant experience after the doctorate in cancer research, survivorship, and/or radiation epidemiology; and excellent computational skills. A strong record of publications demonstrating an ability to collaborate effectively and to lead independent research is required. The candidates will be evaluated on evidence of specific accomplishments; creativity and novelty of scientific vision; sound analytic knowledge and skills; collaborative teamwork, especially across disciplines; ability to work on multiple projects simultaneously and complete projects in a timely fashion; productivity; evidence of effective and efficient leadership of new projects; and skill at effective oral and written scientific communication. Experience working in studies with molecular and genetic components would be advantageous. Candidates must be sufficiently experienced to function independently, both in the development of their own research program and in the mentoring and supervision of more junior investigators.
The successful candidate will develop an independent research program complementing REB’s current research portfolio on subsequent malignancies in cancer survivors. Support will be provided as appropriate, e.g., access to advanced computational resources, state-of-the-art genomics facilities, and mentoring. Applicants may be U.S. citizens, resident aliens, or non-resident aliens with, or eligible to obtain, a valid employment-authorization visa. Salary is commensurate with research experience and accomplishments, and a full package of Federal benefits (including leave, health insurance, life insurance, long-term care insurance, retirement, and a Thrift Savings Plan [401k equivalent]) is available. Selection for this position will be based solely on merit, with no discrimination for non-merit reasons such as race, color, religion, gender, sexual orientation, national origin, political affiliation, marital status, disability, age, or membership or non-membership in an employee organization. NIH encourages the application and nomination of qualified women, minorities and individuals with disabilities. NIH provides reasonable accommodations to applicants with disabilities. If you require reasonable accommodation during any part of the application and hiring process, please notify us. The decision on granting reasonable accommodation will be made on a case-by-case basis. This position is subject to a background investigation.
Interested individuals must send a complete application to Ms. Bessie Sinclair at firstname.lastname@example.org. The application should include a cover letter, curriculum vitae, summary of experience and research accomplishments, succinct statement of research interests (approximately 3 pages), and copies of up to five publications or reprints. Please include in your curriculum vitae, a description of mentoring and outreach activities in which you have been involved, especially those involving women and persons from racial/ethnic, or other groups that are underrepresented in biomedical research. Additionally, three letters of reference are required to be sent directly from the individual writing the letter to the email address listed above, including at least one reference from a collaborator in cancer research, survivorship, or radiation research studies in related disciplines. Any questions also can be directed to the email address above.
More information about this job announcement and about research programs in the Division of Cancer Epidemiology and Genetics and the Radiation Epidemiology Branch are available at http://dceg.cancer.gov/. Review of applications will begin on or about December 31, 2019, but applications will be accepted until the position is filled. DHHS, NIH, and NCI are equal opportunity employers.
About National Institutes of Health
The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation's medical research agency making important discoveries that improve health and save lives. NIH is the largest source of funding for medical research in the world, creating hundreds of thousands of high-quality jobs by funding thousands of scientists in universities and research institutions in every state across America and around the globe. NIH is made up of 27 Institutes and Centers, each with a specific research agenda, often focusing on particular diseases or body systems. The NIH main campus is located in Bethesda, MD